AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

eFFECTOR Therapeutics, Inc.

$0.00 +$0.00 (+0.00%)
OTC · 30 Oct 2026 20:00 UTC
Previous Close
$0.00
Day Range
$0.00 - $0.00
Year Range
$0.00$0.02
Market Cap
941
AVG Volume
1.97K
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-17
Primary Exchange
Other OTCUS
Revenue (USD) · A
020M40M60M2020202120222023
EFTR Revenue (USD) by year
PeriodRevenue (USD)
2023162K
20222.01M
20212.55M
202042M
Net Income (USD) · A
-40M-20M020M2020202120222023
EFTR Net Income (USD) by year
PeriodNet Income (USD)
2023-35.81M
2022-22.66M
202115.8M
2020166K
Operating Income (USD) · A
-40M-20M020M2020202120222023
EFTR Operating Income (USD) by year
PeriodOperating Income (USD)
2023-34.29M
2022-32.4M
2021534K
202015.82M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: EFTR

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 17 Nov 2026.

eFFECTOR Therapeutics, Inc.
EFTR
Stockpicker

Video analysis: EFTR

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: EFTR

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.